Current NDC auxiliary source row compounder:4721

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 72196-0219
Product Ndc: 72196-0219
Product Ndc Digits: 721960219
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Modified del Nido Microplegia
Proprietary Name Suffix: [empty]
Nonproprietary Name: Modified del Nido Microplegia
Dosage Form Name: SOLUTION
Route Name: INTRACORONARY
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Central Admixture Pharmacy Services, Inc.
Establishment Name: Central Admixture Pharmacy Services, Inc.
Establishment Fei: [empty]
Substance Name: MANNITOL; LIDOCAINE HYDROCHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE; SODIUM BICARBONATE
Active Ingredients Info: 3.264 g/40 mL; 131 mg/40 mL; 16.362 meq/40 mL; 1.1 g/40 mL
History Active Ingredients Raw: MANNITOL; LIDOCAINE HYDROCHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE; SODIUM BICARBONATE
History Active Ingredients Info Raw: 3.264 g/40 mL; 131 mg/40 mL; 16.362 meq/40 mL; 1.1 g/40 mL
History Dosage Raw: SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 72196-0219-1
Package Ndc: 72196-0219-1
Package Ndc Digits: 7219602191
Package Ndc11: 72196021901
Package Description: 40 mL in 1 SYRINGE (72196-0219-1)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:4721
Source Row Number: 4721
Source Row Hash: 564f0af68235f387b79dac74f0037b68d616763637fa54a14ba33c0b86708612
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRACORONARY",
    "PRODUCTNDC": "72196-0219",
    "DEASCHEDULE": "",
    "LABELERNAME": "Central Admixture Pharmacy Services, Inc.",
    "SUBSTANCENAME": "MANNITOL; LIDOCAINE HYDROCHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE; SODIUM BICARBONATE",
    "DOSAGEFORMNAME": "SOLUTION",
    "NDCPACKAGECODE": "72196-0219-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Modified del Nido Microplegia",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Modified del Nido Microplegia",
    "PACKAGEDESCRIPTION": "40 mL in 1 SYRINGE (72196-0219-1) ",
    "ACTIVEINGREDIENTSINFO": "3.264 g/40 mL; 131 mg/40 mL; 16.362 meq/40 mL; 1.1 g/40 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:4721
Source Row Number: 4721
Status Scope: package
Lookup Ndc: 72196-0219-1
Lookup Ndc Digits: 7219602191
Product Ndc: 72196-0219
Product Ndc Digits: 721960219
Package Ndc: 72196-0219-1
Package Ndc Digits: 7219602191
Package Ndc11: 72196021901
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 564f0af68235f387b79dac74f0037b68d616763637fa54a14ba33c0b86708612
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33